Table 1.
miRNAs | Source | Cohort Size | Ethnic Population | Detection Method of ncRNAs | AUC | Sensitivity (%) | Specificity (%) | Reference |
---|---|---|---|---|---|---|---|---|
miR-107 | Serum | 115 HCC vs 40 HC | Chinese | Microarray | 0.730 | [33] | ||
miR-122 | Plasma | 40 HCC vs 20 HC | Egyptian | qRT-PCR | 0.96 | 87.5 | 95 | [35] |
miR-122+AFP | Plasma | 40 HCC vs 40 CHC | Egyptian | qRT-PCR | 1 | 97.5 | 100 | [35] |
miR-199a | Serum | 23 HCC vs.17 CH | Egyptian | qRT-PCR | 0.856 | 54.5 | 100 | [36] |
miR-21 | Plasma | 126 HCC vs 30 CH | Japanese | qRT-PCR | 0.773 | 61.1 | 83.3 | [29] |
miR-21 | Plasma | 126 HCC vs 50 HC | Japanese | qRT-PCR | 0.953 | 87.3 | 92.0 | [29] |
miR-21 | Serum | 23 HCC vs.17 CH | Egyptian | qRT-PCR | 0.943 | 100.0 | 81.2 | [36] |
miR-21+AFP | Plasma | 126 HCC vs 30 CH | Japanese | qRT-PCR | 0.823 | 81.0 | 76.7 | [29] |
miR-21+AFP | Plasma | 126 HCC vs 50 HC | Japanese | qRT-PCR | 0.971 | 92.9 | 90 | [29] |
miR-224 | Plasma | 40 HCC vs 20 HC | Egyptian | qRT-PCR | 0.94 | 92.5 | 90 | [35] |
miR-224 | Plasma | 40 HCC vs 40 CHC | Egyptian | qRT-PCR | 0.93 | 87.5 | 97 | [35] |
miR-224+AFP | Plasma | 40 HCC vs 40 CHC | Egyptian | qRT-PCR | 0.93 | 90 | 100 | [35] |
miR-3126-5p | Serum | 115 HCC vs 40 HC | Chinese | Microarray | 0.881 | [33] | ||
miR-34a | Serum exosome | 60 HCC vs 60 HC | Chinese | qRT-PCR | 0.664 | 78.3 | 51.7 | [37] |
miR-34a+AFP | Serum exosome | 60 HCC vs 60 HC | Chinese | qRT-PCR | 0.855 | 68.3 | 93.3 | [37] |
miR-424 | Serum | 123 HCC vs 76 HC | Chinese | qRT-PCR | 0.768 | 75.0 | 72.4 | [38] |
miR-665 | Serum | 80 HCC vs 80 LC | Egyptian | qRT-PCR | 0.930 | 92.5 | 86.3 | [39] |
miR-9-3p | Serum | 35 HCC vs 33 HCV | Egyptian | qRT-PCR | 91.43 | 87.88 | [30] | |
miR-9-3p | Serum | 35 HCC vs 32 HC | Egyptian | qRT-PCR | 91.43 | 87.50 | [30] | |
miR-92a-3p | Serum | 115 HCC vs 40 HC | Chinese | Microarray | 0.705 | [33] | ||
miR-122 + miR-192 + miR-21 + miR-223 + miR-26a + miR-27a + miR-801 | Plasma | 204 HCC vs 60 LC + 75 CHB + 68 HC | Chinese | Microarray and qRT-PCR | 0.864 | 68.6 | 90.1 | [32] |
miR-122 + miR-192 + miR-21 + miR-223 + miR-26a + miR-27a + miR-801 | Plasma | 196 HCC vs 56 LC + 72 CHB + 66 HC | Chinese | Microarray and qRT-PCR | 0.888 | 81.8 | 83.5 | [32] |
miR-29a + miR-29c + miR-133a + miR143 + miR-145 + miR-192 + miR-505 | Serum | 108 HCC vs 47 LC + 51 CHB + 51 HC | Chinese | qRT-PCR | 0.826 | 80.6 | 84.6 | [34] |
miR-29a + miR-29c + miR-133a + miR143 + miR-145 + miR-192 + miR-505 | Serum | 153 HCC vs 71 LC + 68 CHB + 60 HC | Chinese | qRT-PCR | 0.817 | 74.5 | 88.9 | [34] |
miR-29a + miR-29c + miR-133a + miR143 + miR-145 + miR-192 + miR-505 | Serum | 49 HCC vs 42 IHC + 48 HC | Chinese | qRT-PCR | 0.884 | 85.7 | 91.1 | [34] |
miR-29a + miR-29c + miR-133a + miR143 + miR-145 + miR-192 + miR-505 | Serum | Nested cohort: 568 samples from 135 CHB/LC vs 100 samples from 27 HCC | Chinese | qRT-PCR | 0.670 | 55.6 | 78.5 | [34] |
Abbreviations: AFP, alpha-fetoprotein; AUC, area under the curve; CH, chronic hepatitis; CHB, chronic hepatitis B infection; CHC, chronic hepatitis C infection; HC, healthy control; HCC, hepatocellular carcinoma; HCV, hepatitis C virus infection; IHC, inactive HBsAg carrier; LC, liver cirrhosis.